BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 25869677)

  • 41. Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade.
    Enslen H; Tokumitsu H; Stork PJ; Davis RJ; Soderling TR
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10803-8. PubMed ID: 8855261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
    Aoki H; Richmond M; Izumo S; Sadoshima J
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
    [TBL] [Abstract][Full Text] [Related]  

  • 43. c-Jun N-terminal kinase-interacting protein 1 inhibits gene expression in response to hypertrophic agonists in neonatal rat ventricular myocytes.
    Finn SG; Dickens M; Fuller SJ
    Biochem J; 2001 Sep; 358(Pt 2):489-95. PubMed ID: 11513749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Eicosapentaenoic acid prevents endothelin-1-induced cardiomyocyte hypertrophy in vitro through the suppression of TGF-beta 1 and phosphorylated JNK.
    Shimojo N; Jesmin S; Zaedi S; Maeda S; Soma M; Aonuma K; Yamaguchi I; Miyauchi T
    Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H835-45. PubMed ID: 16501010
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential expression of active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates following quinolinic acid excitotoxicity in the rat.
    Ferrer I; Blanco R; Carmona M
    Brain Res Mol Brain Res; 2001 Oct; 94(1-2):48-58. PubMed ID: 11597764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-145-5p targets paxillin to attenuate angiotensin II-induced pathological cardiac hypertrophy via downregulation of Rac 1, pJNK, p-c-Jun, NFATc3, ANP and by Sirt-1 upregulation.
    Lin KH; Kumar VB; Shanmugam T; Shibu MA; Chen RJ; Kuo CH; Ho TJ; Padma VV; Yeh YL; Huang CY
    Mol Cell Biochem; 2021 Sep; 476(9):3253-3260. PubMed ID: 33886061
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endogenous BNP attenuates cardiomyocyte hypertrophy induced by Ang II via p38 MAPK/Smad signaling.
    Chen Y; Yao F; Chen S; Huang H; Wu L; He J; Dong Y
    Pharmazie; 2014 Nov; 69(11):833-7. PubMed ID: 25985580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relation of Cardiotrophin-1 (CT-1) and cardiac transcription factor GATA4 expression in rat's cardiac myocytes hypertrophy and apoptosis.
    He-nan Z; Yan W; Miao-na J; Cai-hua Z; Shen L; Yu-jie J
    Pathol Res Pract; 2009; 205(9):615-25. PubMed ID: 19327894
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alpha1-adrenergic receptors activate AKT via a Pyk2/PDK-1 pathway that is tonically inhibited by novel protein kinase C isoforms in cardiomyocytes.
    Guo J; Sabri A; Elouardighi H; Rybin V; Steinberg SF
    Circ Res; 2006 Dec; 99(12):1367-75. PubMed ID: 17110596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rosuvastatin prevents pressure overload‑induced myocardial hypertrophy via inactivation of the Akt, ERK1/2 and GATA4 signaling pathways in rats.
    Xu X; Zhang L; Liang J
    Mol Med Rep; 2013 Aug; 8(2):385-92. PubMed ID: 23799547
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serine 105 phosphorylation of transcription factor GATA4 is necessary for stress-induced cardiac hypertrophy in vivo.
    van Berlo JH; Elrod JW; Aronow BJ; Pu WT; Molkentin JD
    Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12331-6. PubMed ID: 21746915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phosphorylation of the chromatin remodeling factor DPF3a induces cardiac hypertrophy through releasing HEY repressors from DNA.
    Cui H; Schlesinger J; Schoenhals S; Tönjes M; Dunkel I; Meierhofer D; Cano E; Schulz K; Berger MF; Haack T; Abdelilah-Seyfried S; Bulyk ML; Sauer S; Sperling SR
    Nucleic Acids Res; 2016 Apr; 44(6):2538-53. PubMed ID: 26582913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of peroxisome proliferator-activated receptor-alpha decreases endothelin-1-induced p38 mitogen-activated protein kinase activation in cardiomyocytes.
    Irukayama-Tomobe Y; Miyauchi T; Kasuya Y; Sakai S; Goto K; Yamaguchi I
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S358-61. PubMed ID: 15838320
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin-1beta regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes.
    He Q; LaPointe MC
    Hypertension; 1999 Jan; 33(1 Pt 2):283-9. PubMed ID: 9931118
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p38/RK is essential for stress-induced nuclear responses: JNK/SAPKs and c-Jun/ATF-2 phosphorylation are insufficient.
    Hazzalin CA; Cano E; Cuenda A; Barratt MJ; Cohen P; Mahadevan LC
    Curr Biol; 1996 Aug; 6(8):1028-31. PubMed ID: 8805335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
    Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
    Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinases by methyl methanesulfonate in the liver and brain of rats: implication for organ-specific carcinogenesis.
    Suh Y; Kang UG; Kim YS; Kim WH; Park SC; Park JB
    Cancer Res; 2000 Sep; 60(18):5067-73. PubMed ID: 11016630
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fisetin activates Hippo pathway and JNK/ERK/AP-1 signaling to inhibit proliferation and induce apoptosis of human osteosarcoma cells via ZAK overexpression.
    Fu CY; Chen MC; Tseng YS; Chen MC; Zhou Z; Yang JJ; Lin YM; Viswanadha VP; Wang G; Huang CY
    Environ Toxicol; 2019 Aug; 34(8):902-911. PubMed ID: 31044527
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclovirobuxinum D alleviates cardiac hypertrophy in hyperthyroid rats by preventing apoptosis of cardiac cells and inhibiting the p38 mitogen-activated protein kinase signaling pathway.
    Wu JB; Zhou Y; Liang CL; Zhang XJ; Lai JM; Ye SF; Ouyang H; Lin J; Zhou JY
    Chin J Integr Med; 2017 Oct; 23(10):770-778. PubMed ID: 27048408
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mixed lineage kinase ZAK utilizing MKK7 and not MKK4 to activate the c-Jun N-terminal kinase and playing a role in the cell arrest.
    Yang JJ
    Biochem Biophys Res Commun; 2002 Sep; 297(1):105-10. PubMed ID: 12220515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.